No abstract

No abstract

Conventional photomixotrophic micropropagation systems are inefficient due to the high rates of mortality upon the transfer of plantlets from in vitro to ex vitro conditions. Exogenous medium sugar has been suggested to be the major cause of this problem. The aim of this study was to investigate the role of sucrose supply on the metabolic profile of in vitro-grown potato plantlets subjected to different tissue culture conditions consisting of Murashige and Skoog medium and without sucrose [photoautotrophic (PAT) condition] or with 3% sucrose [photomixotrophic (PMT) condition]. Using gas chromatography-mass spectrometry, we identified a set of 51 different metabolites in leaf tissues during the rooting phase. Most growth parameters, such as shoot length, leaf fresh weight, leaf number, and leaf area/plant, were significantly lower under PMT than under PAT conditions. Moreover, photosynthesis was inhibited due to partial stomatal closure under PMT conditions. The metabolomic profiles along with principal component analysis and hierarchical cluster analysis revealed that the two treatments were characterized by distinct metabolic signatures. PAT leaves were characterized by the accumulation of urea and erythritol. In comparison, PMT leaves were characterized by the accumulation of metabolites belonging to the primary metabolism and catecholamines as well as compounds related to abiotic stress conditions, such as proline, hydroxyproline, asparagine, c-aminobutyric acid (GABA), soluble sugars, and myo-inositol.

No abstract

No abstract

Oxidative stress and chronic inflammation contribute to some chronic diseases. Aronia berries are rich in polyphenols. The aim of the present study was to characterize the cellular antioxidant effect of an aronia extract to reflect the potential physiological in vivo effect. Cellular in vitro assays in three cell lines (Caco-2, HepG2, and SH-SY5Y) were used to measure the antioxidant effect of AE, in three enriched polyphenolic fractions (A1: anthocyanins and phenolic acids; A2: oligomeric proanthocyanidins; A3: polymeric proanthocyanidins), pure polyphenols and microbial metabolites. Both direct (intracellular and membrane radical scavenging, catalase-like effect) and indirect (NRF2/ARE) antioxidant effects were assessed. AE exerted an intracellular free radical scavenging activity in the three cell lines, and A2 and A3 fractions showed a higher effect in HepG2 and Caco-2 cells. AE also exhibited a catalase-like activity, with the A3 fraction having a significant higher activity. Only A1 fraction activated the NRF2/ARE pathway. Quercetin and caffeic acid are the most potent antioxidant polyphenols, whereas cyanidin and 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone showed the highest antioxidant effect among polyphenol metabolites. AE rich in polyphenols possesses broad cellular antioxidant effects, and proanthocyanidins are major contributors. Polyphenol metabolites may contribute to the overall antioxidant effect of such extract in vivo.

No abstract

The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) urgently needs effective antivirals. After over 2 years since the beginning of the pandemic, only a few FDA approved therapeutic options are available to treat the population. Combination therapies have become a standard for the treatment of other infectious diseases such as HIV and hepatitis C due to their improved efficacy compared to monotherapy, reduced toxicity, the ability to prevent the development of resistant viral strains and their potential to treat co-infection. The interest in identifying molecules displaying bioactivity against SARS-CoV-2 has led to extensive search for promising molecules from the natural pharmacopoeia and polyphenols have been shown to display antiviral activity against a number of viruses including SARS-CoV-2. Here we evaluated the in vitro efficacy of two polyphenols, Epigallocatechin gallate (EGCG) and Isoquercetin, in combination with Remdesivir, the first-approved drug for the treatment of severe COVID-19. We confirmed the inhibitory effects of EGCG and isoquercetin against SARS-CoV-2 and demonstrated their strong antiviral synergistic effects with Remdesivir in vitro. These combinational therapies represent an interesting avenue for the treatment of COVID-19 and grant further studies.